Literature DB >> 11731227

Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis.

J Qiao1, K T Bush, D L Steer, R O Stuart, H Sakurai, W Wachsman, S K Nigam.   

Abstract

Together with glial-derived neurotrophic factor (GDNF), soluble factors present in a metanephric mesenchyme (MM) cell conditioned medium (BSN-CM) are necessary to induce branching morphogenesis of the isolated ureteric bud (UB) in vitro (Proc. Natl. Acad. Sci. USA 96 (1999) 7330). Several lines of evidence are presented here in support of a modulating role for fibroblast growth factors (FGFs) in this process. RT-PCR revealed the expression of two FGF receptors, FGFR1(IIIc) and FGFR2(IIIb), in isolated embryonic day 13 rat UBs, which by indirect immunofluorescence displayed a uniform distribution. Rat kidney organ culture experiments in the presence of a soluble FGFR2(IIIb) chimera or a neutralizing antibody to FGF7 suggested an important contribution of FGFs other than FGF7 to the branching program. Several FGFs, including FGF1, FGF2, FGF7 and FGF10, in combination with GDNF and BSN-CM were found to affect growth and branching of the isolated UB, albeit with very different effects. FGF1 and FGF7 were at extreme ends of the spectrum, with FGF10 (more FGF1-like) and FGF2 (more FGF7-like) falling in between. FGF1 induced the formation of elongated UB branching stalks with distinct proliferative ampullary tips, whereas FGF7 induced amorphous buds displaying nonselective proliferation with little distinction between stalks and ampullae. Electron microscopic examination demonstrated that FGF1 treatment induced cytoskeletal organization, intercellular junctions and lumens along the stalk portion of the developing tubules, while the ampullary regions contained 'less differentiated' cells with an abundant secretory apparatus. In contrast, FGF7-induced UBs displayed this 'less differentiated' morphology regardless of position on the structure and were virtually indistinguishable from FGF1-induced ampullae. Consistent with this, GeneChip array analysis (employing a novel nanogram-scale assay consisting of two rounds of amplification and in vitro transcription for analyzing small quantities of RNA) revealed that FGF7-induced UBs expressed more markers of cell proliferation than FGF1, which caused the UB to express cytoskeletal proteins, extracellular matrix proteins, and at least one integrin, some of which may be important in UB branch elongation. Thus, while the various FGFs examined all support UB growth, FGF1 and FGF10 appear to be more important for branching and branch elongation, and may thus play a role in determination of nephron number and patterning in the developing kidney. These in vitro data may help to explain results from knockout and transgenic studies and suggest how different FGFs may, together with GDNF and other factor(s) secreted by MM cells, regulate branching morphogenesis of the UB by their relative effects on its growth, branching and branch elongation and differentiation, thereby affecting patterning in the developing kidney.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731227     DOI: 10.1016/s0925-4773(01)00592-5

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  44 in total

1.  Temporal expression of fibroblast growth factor receptors during primary ligament repair.

Authors:  Simon M Cool; Charles P Snyman; Victor Nurcombe; Mark Forwood
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-12-23       Impact factor: 4.342

2.  Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme.

Authors:  Sunder Sims-Lucas; Valeria Di Giovanni; Caitlin Schaefer; Brian Cusack; Veraragavan P Eswarakumar; Carlton M Bates
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

3.  Organogenesis forum lecture: In vitro kidney development, tissue engineering and systems biology.

Authors:  Sanjay K Nigam; Wei Wu; Kevin T Bush
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

Review 4.  Concise review: can the intrinsic power of branching morphogenesis be used for engineering epithelial tissues and organs?

Authors:  Sanjay K Nigam
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

5.  Developmental Programming of Branching Morphogenesis in the Kidney.

Authors:  Rosemary V Sampogna; Laura Schneider; Qais Al-Awqati
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

6.  The instructive role of metanephric mesenchyme in ureteric bud patterning, sculpting, and maturation and its potential ability to buffer ureteric bud branching defects.

Authors:  Mita M Shah; James B Tee; Tobias Meyer; Catherine Meyer-Schwesinger; Yohan Choi; Derina E Sweeney; Thomas F Gallegos; Kohei Johkura; Eran Rosines; Valentina Kouznetsova; David W Rose; Kevin T Bush; Hiroyuki Sakurai; Sanjay K Nigam
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-02

Review 7.  Secretion without Golgi.

Authors:  Igor Prudovsky; Francesca Tarantini; Matteo Landriscina; David Neivandt; Raffaella Soldi; Aleksandr Kirov; Deena Small; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

Review 8.  Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development.

Authors:  Valerie A Wilson; John T Gallagher; Catherine L R Merry
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 9.  Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

10.  Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching.

Authors:  Mita M Shah; Hiroyuki Sakurai; Derina E Sweeney; Thomas F Gallegos; Kevin T Bush; Jeffrey D Esko; Sanjay K Nigam
Journal:  Dev Biol       Date:  2010-01-06       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.